EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SNORA58 Facilitates Radioresistance via Suppressing JNK1‐Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma

Yinli Zheng iD, Fangyi Liu, Yuhua Huang, Yanfen Feng, Xia Yang, Jinjun Wu, Xin Yang, Xuanhao Lin, Lives Jiang, Tingting Zeng, Yan Li, Xinyuan Guan und 3 weitere

Advanced Science · 2025-10 · 12 (40)

DOI: 10.1002/advs.202508515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.07.2025. Verfasst von Yinli Zheng und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Ferroptosis, Radiation Tolerance, Esophageal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Cancer Innovative Research Program of Sun Yat-sen University Cancer Center, Guangdong Esophageal Cancer Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioresistance represents a substantial challenge in cancer treatment, particularly in esophageal squamous cell carcinoma (ESCC), where the underlying molecular mechanisms remain incompletely understood. Small nucleolar RNAs (snoRNAs), primarily located in the nucleolus, are noncoding RNAs whose roles in ESCC radiotherapy are unclear. In this study, an upregulated snoRNA, SNORA58 is identified in ESCC via a snoRNA PCR array. Furthermore, based on multicenter data, SNORA58 is established as a promising biomarker for predicting response to neoadjuvant chemoradiotherapy (nCRT). Patients with high SNORA58 expression levels presented a lower likelihood of achieving a complete response to nCRT and poorer clinical outcomes. Functionally, SNORA58 enhances cancer cell resistance to radiotherapy without affecting chemotherapeutic sensitivity. Mechanistically, SNORA58 stabilizes CTCF by inhibiting its ubiquitin‐mediated degradation, leading to JNK1 downregulation and subsequent inactivation of the JNK signaling pathway; this disrupts intracellular iron homeostasis, thereby alleviating radiotherapy‐induced ferroptosis. Notably, the administration of a JNK signaling activator significantly restored the radiosensitivity of high‐SNORA58 ESCC cells both in vitro and in vivo. These findings elucidate the first demonstration of SNORA58 as a critical regulator of radioresistance in ESCC and reveal a novel link between snoRNAs and ferroptosis in this specific context, suggesting potential therapeutic strategies for managing ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaFerroptosisRadiation ToleranceEsophageal NeoplasmsRNA, Small NucleolarMitogen-Activated Protein Kinase 8HumansCell Line, TumorMiceAnimalsMaleFemaleGene Expression Regulation, NeoplasticMice, Nude

Stichwörter der Autor:innen

SNORA58esophageal squamous cell carcinomaferroptosis, JNK1radioresistance

Substanzen

RNA, Small NucleolarMitogen-Activated Protein Kinase 8

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of…
  • Department of Pathology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518000,…
  • Department of Pathology, Shantou Central Hospital, Shantou, Guangdong, 515041, P. R. China.
  • Department of Pathology, Affiliated Cancer Hospital and institute of Guangzhou Medical University, Guangdong, 510095, P. R. China.

ORCID-Profile: Yinli Zheng, Jingping Yun

Förderung

  • National Natural Science Foundation of China
  • Cancer Innovative Research Program of Sun Yat-sen University Cancer Center
  • Guangdong Esophageal Cancer Research Institute
  • National Key Laboratory of Human Factors Engineering
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zheng, Y., Liu, F., Huang, Y., Feng, Y., Yang, X., Wu, J., Yang, X., Lin, X., Jiang, L., Zeng, T., Li, Y., Guan, X., Wang, Y., Chen, C., & Yun, J. (2025). SNORA58 Facilitates Radioresistance via Suppressing JNK1‐Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma. Advanced Science, 12(40). https://doi.org/10.1002/advs.202508515

Vancouver

Zheng Y, Liu F, Huang Y, Feng Y, Yang X, Wu J, et al. SNORA58 Facilitates Radioresistance via Suppressing JNK1‐Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma. Advanced Science. 2025;12(40). doi:10.1002/advs.202508515

BibTeX
@article{Zheng2025,
  author = {Zheng, Yinli and Liu, Fangyi and Huang, Yuhua and Feng, Yanfen and Yang, Xia and Wu, Jinjun and Yang, Xin and Lin, Xuanhao and Jiang, Lives and Zeng, Tingting and Li, Yan and Guan, Xinyuan and Wang, Yuanyuan and Chen, Chunyan and Yun, Jingping},
  title = {SNORA58 Facilitates Radioresistance via Suppressing JNK1‐Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {40},
  doi = {10.1002/advs.202508515}
}
Kostenlos starten →